Biotech Breakthroughs Send Roivant and Pharvaris to All‑Time Highs Biotech Breakthroughs Send Roivant and Pharvaris Stocks to New Peaks Fidelity Growth Company Fund: Navigating Q2 2026's Whirlwind Market to Remarkable Outperformance The Biotech Mogul's Midas Touch: Vivek Ramaswamy's Staggering Wealth Surge